ArticleJournal of child and adolescent psychopharmacology2017
Clinical Management of Pediatric Acute-Onset Neuropsychiatric Syndrome: Part II-Use of Immunomodulatory Therapies.
Open access · bronzeAbstract read
In one paragraph
Article in Journal of child and adolescent psychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
14.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.
- Pooled it
- Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children.BMC psychiatry · 2022Trial
- Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome.Journal of child and adolescent psychopharmacology · 2021Trial
- Consideration of Neuroinflammation in Both Pediatric Acute-Onset Neuropsychiatric Syndrome and "Traditional" Obsessive-Compulsive Disorder.The Permanente journal · 2026Article
- Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS): Autoimmune Mechanisms, Diagnostic Controversies, and Therapeutic Implications.Journal of pediatrics, perinatology and child health · 2026Article
- Th17 effector cytokines induce shared and distinct microglial and endothelial cell responses in a mouse model for post-streptococcal encephalitis.Nature communications · 2026Article
- Infection-Associated Pediatric Acute-Onset Neuropsychiatric Syndrome: A Review of Immunological Mechanisms, Clinical Phenotypes, and Therapeutic Strategies.Infectious disease reports · 2026Review
- Developmental Impacts of PANS/PANDAS and Inadequate Support for Children and Families.Child psychiatry and human development · 2026Article
- Recommended Medical Investigations in Pediatric Acute-Onset Neuropsychiatric Syndrome.JAMA network open · 2026Article
- Th17 effector cytokines induce shared and distinct microglial and endothelial cell responses in post-streptococcal encephalitis.bioRxiv : the preprint server for biology · 2026Article
- Relationships between sensory reactivity and occupational performance in children with paediatric acute-onset neuropsychiatric syndrome (PANS).Australian occupational therapy journal · 2025Article
- Occupational performance patterns in children with paediatric acute-onset neuropsychiatric syndrome.Australian occupational therapy journal · 2025Article
- A unique case of food restriction and OCD diagnosed as PANDAS and a review of the literature.Frontiers in psychiatry · 2025Article
- Dopamine receptor autoantibody signaling in infectious sequelae differentiates movement versus neuropsychiatric disorders.JCI insight · 2024Article
- Elevated antibody binding to striatal cholinergic interneurons in patients with pediatric acute-onset neuropsychiatric syndrome.Brain, behavior, and immunity · 2024Article
- Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS): Immunological Features Underpinning Controversial Entities.Children (Basel, Switzerland) · 2024Review
- Differential impact of pegfilgrastim, a recombinant human granulocyte colony stimulating factor, on the neutrophil count of male and female deer mice (Peromyscus maniculatus bairdii).BMC pharmacology & toxicology · 2024Article
- Development of Autoimmune Diseases Among Children With Pediatric Acute-Onset Neuropsychiatric Syndrome.JAMA network open · 2024Article
- Ocular Tics and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS).Diseases (Basel, Switzerland) · 2024Article
- Psychometric Properties of the PANS 31-Item Symptom Rating Scale.Journal of child and adolescent psychopharmacology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors at 2 institutions in 1 country.
Jennifer FrankovichStanford PANS Clinic and Research Program at Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.
Susan SwedoPediatrics and Developmental Neuroscience Branch, National Institute of Mental Health, Bethesda, Maryland.
Tanya MurphyRothman Center for Pediatric Neuropsychiatry, Pediatrics and Psychiatry, University of South Florida Morsani College of Medicine, Tampa, Florida.
Russell C DalePaediatrics and Child Health, Institute for Neuroscience and Muscle Research, the Children's Hospital at Westmead, University of Sydney, Sydney, Australia.
Dritan AgalliuPathology and Cell Biology (in Neurology and Pharmacology), Columbia University, New York, New York.
Kyle WilliamsPediatric Neuropsychiatry and Immunology Program in the OCD and Related Disorders Program, Harvard Medical School, Boston, Massachusetts.
Michael DainesAllergy, Immunology, and Rheumatology, The University of Arizona College of Medicine Tuscon, Tuscon, Arizona.
Mady HornigEpidemiology, Center for Infection and Immunity, Columbia University Medical Center, New York, New York.
Harry ChuganiPediatric Neurology, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware.
Terence SangerNeurology, University of Southern California Pediatric Movement Disorders Center, Children's Hospital of Los Angeles, Los Angeles, California.
Eyal MuscalPediatric Rheumatology, Baylor College of Medicine, Houston, Texas.
Mark PasternackPediatric Infectious Disease, Harvard Medical School, Boston, Massachusetts.
Michael CooperstockPediatric Infectious Diseases, University of Missouri School of Medicine, Columbia, Missouri.
Hayley GansPediatric Infectious Diseases, Stanford University School of Medicine, Stanford, California.
Yujuan ZhangPediatric Rheumatology, Tufts University School of Medicine, Boston, Massachusetts.
Madeleine CunninghamMicrobiology and Immunology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Gail BernsteinChild and Adolescent Psychiatry, University of Minnesota Medical School, Minneapolis, Minnesota.
Reuven BrombergPediatric Rheumatology, Miami Rheumatology, LLC, Miami, Florida.
Theresa WillettStanford PANS Clinic and Research Program at Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.
Kayla BrownStanford PANS Clinic and Research Program at Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.
Bahare FarhadianStanford PANS Clinic and Research Program at Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.
Kiki ChangStanford PANS Clinic and Research Program at Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.
Daniel GellerPediatric OCD and Tic Disorder Program, Harvard Medical School, Boston, Massachusetts.
Joseph HernandezStanford PANS Clinic and Research Program at Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.
Janell SherrStanford PANS Clinic and Research Program at Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.
Richard ShawPsychiatry and Behavioral Sciences, Child and Adolescent Psychiatry, Stanford University School of Medicine, Palo Alto, California.
Elizabeth LatimerPediatric Neurology, Georgetown University Hospital, Washington, District of Columbia.
James LeckmanChild Psychiatry, Psychiatry, Psychology and Pediatrics, Yale Child Study Center, Yale School of Medicine, New Haven, Connecticut.
Margo ThienemannStanford PANS Clinic and Research Program at Lucile Packard Children's Hospital, Stanford University School of Medicine, Palo Alto, California.
National Institute of Mental Health · USStanford University · US
Funding
Developing a microfluidic human neurovascular unit system to investigate genetic and age-related risk factors in Alzheimer's diseaseR01AG078352 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Dritan Agalliu, Andrew Alexander Sproul · 2025 to 2026
$837kNIA NIH HHS R01 AG078352
Abstract
PubMed holds no abstract for this paper.
Indexed as
corticosteroidsIVIGNSAIDsPANDASPANSplasmapheresis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.